JCAHO issues new look-alike, sound-alike drug list

Article

On Aug. 30, the Joint Commission on Accreditation of Healthcare Organizations posted a new look-alike/sound-alike drug list data file on its 2005 National Patient Safety Goals (NPSG) Web page. This is a list selected after a review of error report descriptions received by the Institute for Safe Medication Practices (ISMP) and the United States Pharmacopoeia and other previously published lists.

Recent Videos
Related Content
The Importance of Pharmacy-Sponsored Programs for Driving Medication Adherence

The Importance of Pharmacy-Sponsored Programs for Driving Medication Adherence

Brian Nowosielski
December 9th 2024
Article

A.J. Lipka discusses the impact of pharmacy-sponsored programming.

American Pharmacies: Powering the Profession Through Leadership

American Pharmacies: Powering the Profession Through Leadership

Brian Nowosielski
December 3rd 2024
Podcast

Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.

Virtual Care Provides Similar Outcomes for Patients with Diabetes | ASHP Midyear

Virtual Care Provides Similar Outcomes for Patients with Diabetes | ASHP Midyear

Killian Meara
December 9th 2024
Article

Research also showed that the percentage of no-show appointments was slightly higher in a pre-virtual group compared to a post-virtual group.

How Centralized Fulfillment is Making Pharmacy More Efficient

How Centralized Fulfillment is Making Pharmacy More Efficient

Brian Nowosielski
November 25th 2024
Podcast

Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.

SGLT2 Inhibitor Outcomes Vary When Stratified By Patient Race | ASHP Midyear

SGLT2 Inhibitor Outcomes Vary When Stratified By Patient Race | ASHP Midyear

Lauren Biscaldi, MS, Managing Editor
December 9th 2024
Article

Efficacy data for dapagliflozin and empagliflozin in a group of Asian patients were evaluated.

HPV Vaccine Programming More Cost-Effective for Patients Under 26

HPV Vaccine Programming More Cost-Effective for Patients Under 26

Brian Nowosielski
December 9th 2024
Article

Researchers analyzed the expansion of HPV vaccination for mid-adults defined as people 26 years or older with increased HPV risk.

© 2024 MJH Life Sciences

All rights reserved.